🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assessment of the effect of BI 1356 or Placebo on prolongation of the QT in...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT02183467
Treatments Being Tested
Investigators propose to examine the effect of 12 weeks of Linagliptin, a d...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2013-10
Trial ID
NCT01969084
Treatments Being Tested
To evaluate the efficacy and safety of linagliptin compared to placebo when...
Status
Completed
Location
China-Japan Friendship Hospital
Start Date
2016-09-30
Trial ID
NCT02897349
Treatments Being Tested
To investigate the efficacy, safety, and tolerability of linagliptin 5 mill...
Status
Completed
Location
Syed Research Consultants, LLC
Start Date
2014-09-23
Trial ID
NCT02240680
Treatments Being Tested
to determine safety, efficacy and tolerability of BI 1356 versus placebo...
Status
Completed
Location
1218.43.10027 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00800683
Efficacy and safety of BI 1356 compared to placebo in patients with type 2 ...
Status
Completed
Location
1218.35.10002 Boehringer Ingelheim Investigational Site
Start Date
2008-12
Trial ID
NCT00819091
Type 2 diabetes is a national epidemic. Diabetes has undesirable effects on...
Status
Completed
Location
The George Washington University Medical Faculty Associates
Start Date
2015-04
Trial ID
NCT02467478
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1218.17.10003 Boehringer Ingelheim Investigational Site
Start Date
2008-01
Trial ID
NCT00601250
Treatments Being Tested
The objective of the current study was to investigate safety, tolerability,...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT02173665
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Madalen...
Status
Recruiting
Location
EMS
Start Date
2024-11-18
Trial ID
NCT04670666